{"entity":{"id":"nct07545356","kind":"trial","name":"A Study of KIVU-305 in Participants With Locally Advanced or Metastatic Solid Tumors","aka":[],"tldr":"A phase 1 trial of KIVU-305 run by Kivu Bioscience Inc., now recruiting.","summary":"A Study of KIVU-305 in Participants With Locally Advanced or Metastatic Solid Tumors is a phase 1 interventional study registered as NCT07545356 by Kivu Bioscience Inc., with 76 participants planned, started 2026-05-25. Conditions recorded: Solid Tumors. Interventions recorded: KIVU-305.","status":"recruiting","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT07545356","url":"https://clinicaltrials.gov/study/NCT07545356"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["kivu-305"],"companies":["kivu-bioscience"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07545356","phase":"1","setting":"A Phase 1 Dose-Finding and Dose Optimization-Expansion Study of KIVU-305 in Participants With Locally Advanced or Metastatic Solid Tumors","sponsor":"Kivu Bioscience Inc.","enrolled":76,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07545356/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"kivu-305","kind":"drug","name":"KIVU-305","route":"/drugs/kivu-305/"}],"company":[{"id":"kivu-bioscience","kind":"company","name":"Kivu Bioscience","route":"/companies/kivu-bioscience/"}]}}